"It's not secret that small caps perform best coming out of recessions; further, if we want to ride the small-cap rally for maximum gains, we should similarly rotate into small-cap value stocks," says Louis Basense.

The contributing editor to The Oxford Club explains, "Thankfully, it's an easy transition to make. I say that because the most attractive small-cap value investment is sitting right under our noses. No one on Earth is better at discovering small-cap value investments than David Dreman.

Two growth stock specialists have turned bullish on the prospects for medical equipment maker Varian Medical Systems (VAR), despite uncertainty surrounding health care legislation.

Here's a look at the company from Louis Basenese, senior analyst with The Oxford Club, along with commentary from Mark Skousen, from his specialty service, The Turnaround Alert.

Mark Skousen suggests, "One stock that should benefit from 'ObamaCare' is Varian Medical Systems, the world's leader in radiation technology and X-ray imaging.

Two of the newsletter industry's leading growth stock advisors remain bullish on the prospects of online retailer Amazon.com (NASDAQ: AMZN), based on growth in not only online retailing but new market areas ranging from the Kindle e-reader to cloud computing.

Mike Cintolo, editor of The Cabot Top Ten Report, explains, "Amazon.com recently blew away earnings expectations." Meanwhile, Alexander Green, investment director at The Oxford Club, says, "In our view, the best lies ahead for the company." Here are their reviews.

Mike Cintolo continues, "Amazon announced that its Kindle e-book reader is now its most popular selling item, both in units and in dollars. That led to a big acceleration in revenue growth (28%, the fastest in five quarters), while earnings leaped 67%.

"Gilead Sciences (NASDAQ: GILD), one of the world's largest biotechs, is a stock for all seasons," say growth expert Alexander Green.

The investment director for The Oxford Club explains, "It's a fine company with a solid balance sheet, a recession-proof business and excellent growth prospects."

"Gilead focuses on three main areas, including cardiovascular conditions and respiratory diseases. (Many may have taken its anti-influenza drug Tamiflu, Letairis to treat hypertension, or Macugen to treat macular degeneration.)

"Vice stocks have consistently outperformed most other market sectors, especially during recessionary times," says Alexander Green, whose 'Seven Deadly Sins Portfolio' is up 59% in six months.

One strong performer in that portfolio is Smith & Wesson Holding (NASDAQ: SWHC). Here, the investment director of The Oxford Club explains why investors should load up on the gun maker.

"Smith & Wesson has been a partner in law enforcement since the 1800s, developing crime-fighting tools that set the standard for the field.

"Diageo (NYSE: DEO), the world's largest spirits maker, offers solid and safe dividend, as well as the potential for strong capital appreciation," says Louis Basenese.

The senior analyst for the prestigious The Oxford Club suggests, "Moreover, investors can also prepare for a US dollar decline by buying these shares." Here's his bullish outlook.

"Headquartered in London, roughly 70% of the company's sales come from outside the United States. So any dollar dip will increase the value of our ADRs.

"Moreover, management concedes that positive currency tailwinds in the other countries where Diageo sells spirits will help the company easily grow earnings by double digits this year.

"Playboy Enterprises (NYSE: PLA) is a speculative stock, with plenty of potential but also downside risk," suggests Alex Green. In The Oxford Club, he looks at the firm's turnaround potential.

"Yes, Playboy's publishing empire is a big money loser. But it still has one of the most recognized brands in the world. The rabbit head logo generates more than $1 billion in licensing fees annually.

"When you consider that Playboy Enterprises has a market capitalization of a little over $100 million, you begin to see how undervalued this stock is.

"Over the past year, ITC Holdings (NYSE: ITC) has been focused on identifying ways to integrate wind and other renewable resources into the power grid," notes growth stock expert Alexander Green.

In The Oxford Club Communique, he explains, "This young company -- that despite being in the midst of the biggest economic slowdown in more than 70 years -- is taking in more than $600 million in annual revenue, enjoying 46% operating margins and experiencing 72% quarterly profit growth.

In a difficult economic environment, it is often wise for investors to consider stocks in more defensive and relatively recession-resistant sectors. And one such area is food and beverage stocks.

As the long-standing market maxim goes, consumers can pull back on spending for vacations, remodeling, and new cars, but they still need to eat and drink.

In that light, I turned to nine leading newsletter advisors who serve up their current favorite ideas in the food and beverage sector:

This post is part of a seven article report -- Food for thought: Best bets in food & beverage stocks..

"If you're buying stocks to meet long-term investment goals, now is an excellent time to do some bargain hunting," says Alexander Green. In The Oxford Communique he looks to Diageo (NYSE: DEO).

"One good place to start is with Diageo. We like the outlook for company, which is the world's largest spirit maker. In good times or bad, people drink. According to some studies, even more during the bad times.

"With eight of the top 20 brands, and unparalleled marketing and distribution operations, Diageo is the best way to tap into the globe's steady demand for high-quality spirits.

Two leading growth stock expert, Brandon Clay, editor of Invest with an Edge, and Alexander Green, editor of The Oxford Club, turn to automated blood testing equipment maker Immucor (NASDAQ: BLUD) as a recession-resistant buy.

Clay suggest, "A good bet is to go with the strongest stock in that particular sector at the time of your pickThat way, the company you select at least has the momentum of the sector backing it. Typically the medical industry performs better than the overall market in a downturn. This recession has been no different.

"As we dug deeper into health care, one company surfaced that was worth our attention. Immucor is a blood testing equipment manufacturer specializing in pre-transfusion diagnostics.

"Established in 1982, they brought their first patent to market four years later. Since then they've become a leader in blood diagnostics and blood bank technology.

"Clean Harbors (NYSE: CLH), the nation's largest hazardous waste firm, represents a great way to add some recession-resistance to your portfolio," says growth stock expert David Fessler.

The contributing editor to The Oxford Club adds, "This stock is also a way to get paid from cleaning up our nation's biggest environmental messes in the process." Here's the advisor's review.

"Clean Harbors is a one-stop clean-up shop for waste. We're talking hazardous waste, toxic chemicals, radioactive materials and biologic or infectious waste.

"With a superior portfolio of over 100 waste management facilities, Clean Harbors is North America's largest vertically integrated environmental services and hazardous waste-treatment company.

"The company has been around for more than 120 years. It currently operates in more than 130 countries, selling hundreds of products, including Ultane (an inhaled anesthetic), the anti-infective Biaxin XL, and TriCor and Niaspan to manage cholesterol.

"However, Abbott's biggest growth driver is Humira, a blockbuster drug that targets autoimmune disorders. The drug has received FDA approval to treat a number of diseases, including rheumatoid arthritis, psoriasis and Crohn's disease.

"Steris Corp. (NYSE: STE), the world's leading maker of sterilization and decontamination equipment, is a fast-growing company in a recession-proof industry," notes growth stock expert Alexander Green.

The contributing editor to industry-leading The Oxford Club explains, "Every year, 6.5 billion medical devices are sterilized in Steris equipment. Even gun-shy investors can afford to step up and buy a few shares of this one."

"Researchers and professionals in the pharmaceutical, medical device manufacturing and health care industries count on Steris to keep their environments germ-free.

"In North America, Steris leads in products like lights, booms and tables. It also offers consumable products, such as hand sanitizers, washing lotions and skincare products.

"This company has a long history, datingo its beginnings as The American Sterilizer Company in 1894. It was already a world leader in sterilization products in the 19th century. Today, the company employs more than 5,300 people in more than 60 countries. Sales hit $1.32 billion over the past 12 months.

"And under the leadership of new CEO Walt Rosebrough, Steris is re-energizing its sales, marketing and R&D. It's also cutting costs to enhance efficiencies and improve profits.

"As my high school football coach always quipped, 'Offense may win fans, but defense wins games,'" says leading growth stock expert Louis Basenese.

Here, the Oxford Club associate investment director takes a look at his three favorite defense stocks, noting, "When it comes to investing in the current environment, I'm convinced that you can't go wrong with this trio of companies."

"In my view, this sector willl never fall out of favor. The recent development with Russia serves to underscore another point I've been making for years. We always have to be prepared.

"Or, put another way, there will never be a good time for defense cuts, lest we want to leave our country vulnerable.Add it all up, and we can expect defense companies to enjoy steady demand. Even in the face of a recession.

"As the CEO of Rockwell notes, there has been absolutely no fallout in the defense industry as a result of the worldwide credit meltdown or other economic woes. So here's a quick run-down on the three defense companies we prefer for investors.